Pharmacodynamic and Pharmacokinetic Dose Ranging Study of Tiotropium Bromide Administered Via Inhalation Solution in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Phase 2 Completed 155 enrolled Glenmark Specialty S.A.

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Pharmacodynamic and Pharmacokinetic Dose Ranging Study of Tiotropium Bromide Administered Via Inhalation Solution in Patients With Chronic Obstructive Pulmonary Disease (COPD).

Timeline

Start: 2017-03-24
Primary completion: 2017-07-31
Completion: 2017-07-31

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Tiotropium	Other / unclassified	—	Inhaled

Pharmacodynamic and Pharmacokinetic Dose Ranging Study of Tiotropium Bromide Administered Via Inhalation Solution in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Summary

Timeline

Drugs

Indications